Opsin Biotherapeutics
Pre-clinicalRevolutionizing pain treatment through optogenetic gene therapies—an alternative to opioids and spinal cord stimulators.
Founded
2020
Focus
Gene TherapyOphthalmology
About
Revolutionizing pain treatment through optogenetic gene therapies—an alternative to opioids and spinal cord stimulators.
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile